Eupraxia Pharmaceuticals is trading 5% up today at $6.47, rebounding from yesterday’s 5.5% drop as investors shift into defensive healthcare names.
- The move appears driven by a broader rotation into the healthcare sector, which is up over 2% today, rather than company-specific news or earnings.
- The stock is recovering from recent volatility; previous notable updates include board additions on July 7 and clinical data releases earlier this year.